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     ICD-85 is a combination of three poly-peptides, ranging from 10,000 to 30,000 Dalton, derived from 
the venoms of an Iranian brown snake (Agkistrodon halys) and a yellow scorpion (Hemiscorpius 
lepturus). Labeling of this ICD-85 was successfully achieved with 
99m
Tc, through direct method using 
SnF2 as reducing agent. Labeled ICD-85 was injected into mice to determine the excretion pathway. The 
results show that the maximum labeling yield (>75%) was obtained by using 30 μg of ICD-85 in 
phosphate buffer (60 μl, pH 7.1) at room temperature. Bio-distribution studies with radiolabeled ICD-85 
shows moderate clearance of the complex from blood. The improvement of the immunotherapeutic 
treatment of cancer requires a better knowledge of the biological actions of the ICD-85 since tissue 
distribution studies are very important for clinical purpose. 
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INTRODUCTION  
     Snakes and scorpions are widespread in all 
urban and rural areas. Hemiscorpius lepturus is 
the most common scorpion's species [1-5]. 
Venom is a mixture of proteins, peptides (poly-
peptides) and toxin fractions which can affect the 
exposed fibers and the muscles directly or 
through motor nerves, causing neuromuscular 
intoxication. Most of these proteins and 
polypeptides, existing as monomers, but some of 
them form complexes in the venom. Venom can 
cause various effects such as pain, inflammation, 
muscle paralysis or death in people. Moreover, 
scorpion venoms are mainly rich sources of short-
chain toxins composed of 30–40 amino acid 
residues and are mainly cross-linked by two or 







) [2, 6-9]. 
ICD-85 is a combination of three peptides that 
range from 10 to 30 kDa and are derived from the 
venom of an Iranian snake (Agkistrodon halys) 
and a scorpion (Hemiscorpius lepturus) [10-14]. 
Previous studies revealed an inhibitory effect of 
ICD-85 (venom derived peptides) on breast 
cancer cell line MDA-MB231 [10]. ICD-85 was 
also confirmed by in vivo studies to suppress the 
breast tumor in mice [11]. Finding the bio-
distribution and localization of these venoms in 
different body tissues is useful for preparation of 
good agent for clinical use.  A common method 
to see the bio-distribution of an unknown 
compound in different tissues is labeling with 
radioisotopes. For therapy by venom, there are 
reports that present the cytotoxic activity of 
various venoms through employing some cancer 
cells [15-17]. It was indicated that a protein from 
Cobra venom was selectively cytotoxic to cancer 
cells [15].  
Labeling of a compound with radioisotopes is a 
proper approach for observing the bio-distribution 
in vital organs. Technetium-99m (
99m
Tc) has 
numerous applications as a tracer, and remains at 
the forefront of such investigations due to its 
ideal nuclear characteristics (6-hour half-life and 









Tc generator, and well-
established labeling chemistries [1, 18, 19]. 
The aim of this study is the labeling of ICD-85, 
its stability study and its bio-distribution  in mice, 
so that the biological behavior of the labeled 
compound is evaluated in animal through bio-
distribution  assay. 
 
MATERIALS AND METHODS  
     All chemical materials were purchased from 
Sigma and Fluka (Germany) company. 




Tc generator. Venom (ICD-85) was 
provided by Razi Vaccine and Serum Research 
Institute of Iran [10-14]. ICD-85 derived from 
scorpion and snake venom (Iranian brown snake 
(Agkistrodon halys) and yellow scorpion 
(Hemiscorpius lepturus)) consisted of three poly 
peptides, ranging from 10,000 to 30,000 Dalton. 
The ICD-85 polypeptides were selected based on 
a study of crude venom cytotoxicity. Similar to 
previous researches by Zare et al. [10-14], the 
venom indicated antigrowth activity on some cell 
lines. Then, the venoms were fractionated; the 
active peptides were isolated and tested on the 
cell lines.   
The ICD-85 was labeled with 
99m
Tc through 
direct method using stannous fluoride as reducing 
agents. The direct method of radiolabeling 
usually uses a reducing agent to convert a 
disulfide bonds into free thiols that are able to  
bind the Technetium-99m quite efficiently. This 
procedure often applies to peptides, proteins and 
antibodies or their fragments because of their 
disulfide bonds. 
Preliminary studies were done to establish the 
optimum conditions for obtaining the highest 
yield of labeled venom. In this study, labeling 
process was divided into two steps. As for first 
step (Figure 1), 10 microgram of (in distilled 
water 10 μg/10μl) SnF2 was added to vial 
containing ICD-85 (in phosphate buffer, pH=7.1, 
1M) for the reduction of S-S bonds (15min). In 
the second step (Figure 2), Na
99m
TcO4 (2mCi) 




Tc generator was 
added to the reaction vial. The pH was adjusted to 
7.1. The mixture was incubated for 15 min at 
room temperature under vacuum condition. Then, 
a volume 0.5 ml saline solution was added to 
reaction vial in order to interrupt the labeling 
reaction [1, 18]. Gel chromatography separated 
peptides and proteins on the basis of size. In this 
system, Small molecules diffuse into the pores of 
the gel beads and therefore move through the bed 
more slowly, while large molecules move through 
the bed quickly. Chromatography set-up 
(Sephadex) for labeled ICD-85 separation is 















Figure 3. Chromatography set-up (Sephadex) for labeled ICD-85 separation 
 
Experimental Animals 
     Animal studies were performed in 
compliance with the regulations of the Nuclear 
Sciences and Technology Research Institute 
(NSTRI), and with generally accepted 
guidelines governing such works. To pursue 
that aim, cancerous male mice, weighing 
between 25 and 30 g were injected with venom 
and investigated. Melanoma cancer was created 
by B16F10 cell line.  
Bio-distribution  
     Bio-distribution  study by killing the mice is 
an important step for preclinical investigations. 
The data obtained by dissecting and counting 
the organs is more accurate than other methods, 
while other methods such as SPECT imaging 
can also be used. Mice were injected with a 
saline solution containing radiolabeled ICD-85 
into the tail vein. For ex vivo counting, the 
animals were killed and various organs were  
 
 
dissected, weighed and counted for 
radioactivity. Data were expressed as the 




     In our method, 
99m
Tc was labeled ICD-85 
with high efficiency and good stability.  After 
direct labeling of ICD-85 with Tc-99m, the 
complex was loaded on sephadex 
chromatography column (1.5*5.5cm) to 
separate the labeled ICD-85. The column was 
eluted by phosphate buffer (pH=7.1, 0.1 M) and 
collected into 1ml tubes. Finally, these tubes 
were counted by well type counter (Quantitative 
gamma counting was performed on an 
EG&G/ORTEC (Model 4001M, Jackson, USA) 
Mini Bin and Power Supply counter.). 
According to the results, the efficiency of 
radiolabeling was >75%. The results of 
radiolabelling are shown in Figure 4.
 
Figure 4. Chromatogram shows counts of 1ml tubes after radiolabeling and counting in NaI(Tl) well type counter 
 
When the mice were injected with the labeled 
ICD-85, they did not show any clinical 
symptoms. After 30 min, they were sacrificed 
and their organs dissected and counted by well 
type counter. Bio-distribution study in normal 
mice presented moderate clearance of the 
compound from blood. The Bio-distribution 
results for labeled ICD-85 and 
99m
TcO4 are 
shown in Tables 1, 2 and Figures 5 and 6. 
 




                Table 1. The Bio-distribution  of labeled ICD-85 and 99mTcO4 in mice after 30 min post injection 
Organs 99mTc-ICD85 (ID/g%) 99mTcO4 (ID/g%) 
Blood 3.72±0.2 2.2±0.15 
Heart 2.12±0.15 3.1±0.2 
Lung 3.01±0.16 3.83±0.22 
Tumor 1.87±0.11 1.79±0.12 
Stomach 1.36±0.08 10.04±1.16 
Intestine 0.84±0.06 1.97±0.12 
Thyroid 1.43±0.07 14.33±1.8 
Liver 6.1±0.4 4.15±0.3 
Spleen 1.79±0.08 2.2±0.13 
Kidney 8.2±0.5 3.61±0.17 
Tissue 0.82±0.04 1.65±0.1 
Brain 0.3±0.02 0.4±0.04 
 







Figure 5. The bio-distribution  of labeled ICD-85 in mice 
 
 
Figure 6. The bio-distribution  of  99mTcO4 in mice 
 
DISCUSSION 
     In order to study ICD-85 bio-distribution, this 
material was labeled with sodium pertechnetate 
(Na
99m
TcO4).   
99m
Tc is the        most     important  
 
 
radionuclide in nuclear medicine applications; 
about 85% of the radiopharmaceuticals used in 
diagnostic applications are based in this 
substance. The reasons for this central position 
include favorable nuclear physical characteristics 
Percentage Organs 
130% Tumor / Thyroid 
22.8% Tumor / Kidney 
30% Tumor / Liver 
88% Tumor / Heart 
62% Tumor / Lung 




and the availability. The half-life is short enough 
to enable the administration of reasonably high 
doses which, in turn, allow for good quality 
images. Moreover, 
99m




Tc generators in high quality and at low 
cost [1, 18]. For 
99m
Tc labeling, a large number of 
techniques have been developed and extensively 
reviewed [1, 20-23]. They may be classified into 
three main categories: direct labeling, preformed 
chelate approach, and indirect labeling approach 
[22]. The direct labeling approach usually uses a 
reducing agent to convert a number of disulfide 
linkages into free thiols, which are able to bind to 
99m
Tc efficiently. It has been reported that both 
thiolate sulfur and imidazole nitrogen are 
involved in bonding with 
99m
Tc [24]. This method 
applies mostly to proteins or their fragments 
because of their disulfide bonds. The direct 
labeling method is simple and easy to perform 
and does not require synthetic modification nor 
blocking and deblocking of functional groups. 
SnF2 was used to reduce the disulfide bridges to 
provide sulfahydril groups for 
99m
Tc binding. 
In this study, the labeling of ICD-85 is 
successfully achieved with Tc-99m using direct 
SnF2 reduction procedures. Tc-99m radionuclide 
is a pure gamma emitter which is ideal for 
medical scanning (gamma energy 140 keV). Also 
the dose delivered to the organs of interest may 
be extremely negligible compared to many other 
radionuclides. Bio-distribution study in normal 
mice presented moderate clearance of the 
compound from blood (The uptake of ICD-85 in 
blood after 30 minutes was 3.72±0.2 (ID/g%), 
which shows the moderate clearance of labeled 
ICD-85 from the body). Results showed that both 
liver and kidneys comprise secretion pathway of 
the labeled ICD-85. No significant accumulation 
in the stomach and thyroid was observed, 
indicating that there was low free 
99m
Tc in the 
labeled ICD-85. Liver and kidney uptake after 30 
minutes were 6.1±0.4and 8.2±0.5 (ID/g%) 
respectively. The concentration of labeled ICD-
85 in the stomach and thyroid (target organs for 
free pertechnetate) was almost insignificant.   
 
CONCLUSION 
     Radiolabeling of the ICD-85 was 
accomplished in order to assess the most 
optimum conditions for labeling and potential 
usage in biological evaluation. Furthermore, the 
conjugate showed acceptable specific activity and 
demonstrated considerable radiochemical 
stability. These properties suggest that 
99m
Tc 
labeling of ICD-85 may be a useful tool for in 
vivo studies and is an excellent approach to 
follow the process of bio-distribution and kinetics 
of toxins. 
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